Mole Medical's Ophthalmic Image Storage and Transmission Software Receives Regulatory Approval
Mocular Medical
Ophthalmic Medical Device Application Developer
Recently,HangZhou Mocular Medical Technology Inc.(NEEQ: 832652)“"Ophthalmic Imaging Storage and Transmission Software"Obtained the Medical Device Registration Certificate issued by the Zhejiang Provincial Drug Administration, with the registration certificate number Zhejiang Medical Device Registration No. 20252211151.
This ophthalmic imaging storage and transmission software relies on multi-modal image data fusion technology and an intelligent auxiliary screening engine,Deeply Coupled with the Company's Fully Automatic Fundus Camera, forming a complete closed loop of "real-time data collection by smart hardware - second-level analysis by cloud-based algorithms - automatic generation of structured reports," enabling the company to take the lead in building up "Equipment + Data + Service"Trinity Ecological System.
The acquisition of the product registration certificate, marking an important breakthrough in the company's strategic layout in the field of smart healthcare,By entering the primary healthcare scene, filling the market gap for下沉的专业眼科资源`, laying the foundation for the subsequent expansion of chronic disease management, hierarchical medical treatment and other businesses.`
# Product Introduction
Registration Certificate Number：Zhejiang Medical Device Registration No. 20252211151
Name of Registrant：HangZhou Mocular Medical Technology Inc.
Product Name：Ophthalmology Imaging Storage and Transmission Software
Management Category: Class II
Model and Specifications：MICS
Structure and Composition:The product is standalone software, using a C/S architecture, with a USB drive as the carrier, and belongs to a regional-level PACS. Functional modules include: login module, patient management, report module, personal center, image viewing module, and system management.
Scope of Application：The product is used for transmitting, processing, storing, and viewing fundus images captured by fundus cameras, assisting doctors in completing remote ophthalmology film-reading operations.。
# Market Overview
Approved Imported Ophthalmic Imaging Management Software
Approved Ophthalmic Imaging Management Software Made in China
ZEISS FORUM Ophthalmic Imaging Management System integrates data consolidation, analysis, and management. It can process raw data from different devices and formats.Integration across devices, time, and space, achieving seamless data integration and efficient utilization. Whether it's fundus photography, OCT examination, or visual field testing, FORUM can intelligently manage examination data, access data anytime and anywhere, and efficiently collaborate to share the new digital diagnosis and treatment process.
In addition, the FORUM ophthalmic imaging management system also has powerful image analysis capabilities.Through the fundus disease, glaucoma, cataract, and corneal refractive surgery work platforms, which can automatically analyze and identify imaging data, helping doctors make more accurate diagnoses and develop personalized treatment plans. It not only optimizes ophthalmic workflows but also enhances the precision of diagnosis and treatment, bringing better outcomes for patients.
Bigvision Medical's ophthalmic image storage, processing, and analysis system is based on advanced image processing and artificial intelligence analysis algorithms, performing storage, processing, and analysis of multimodal ophthalmic images such as optical coherence tomography (OCT) and fundus color photography.Provide auxiliary diagnostic opinions for 18 common fundus lesions such as age-related macular degeneration, diabetic retinopathy, and glaucoma., effectively improving the efficiency of clinical disease diagnosis and treatment, and providing systematic solutions for large-scale screening and management of ophthalmic diseases.
With the further integration of artificial intelligence and big data technologies, the global market for ophthalmology medical imaging management systems will also achieve significant growth. Data Bridge Market Research predicts that by 2028, the global ophthalmology PACS market size will reach 201 million US dollars, with a compound annual growth rate of 7.33%.In China, the ophthalmology PACS market has reached billions of yuan and continues to grow at a steady annual growth rate.。
From a range of products, it can also be concluded that in order to stand out in a highly competitive market, these platformsNot only must it possess strong data integration and analysis capabilities, which can efficiently collect, organize, and deeply analyze multimodal imaging data from different medical devices, revealing the intrinsic patterns and characteristics of eye diseases;It also needs to be compatible with multi-brand, multi-vendor equipment from the upstream supply chain., through the deep integration of AI technology with various devices, provides comprehensive support for data transmission, processing, integration, and analysis, thereby ensuring the efficiency, continuity, and stability of medical services.
# AboutMocular Medical
Mocular Medical focuses onOphthalmic Digital Devices and Ophthalmic Medical Information Systems, The main products include:EyeMocular Medical Equipment and Devices, such as portable intelligent fundus cameras, self-service vision screening devices, digital slit lamps, corneal topographers, etc.;Software System, such asSurgical Microscope Video System, HD Surgical Camera System, Slit Lamp Image Processing System, Ophthalmic Image Processing System, etc.;Big Data and Cloud Services, such asThrough the ophthalmic big data cloud storage system, provide users with vision health solutions.
The company's semi-annual report data shows,Total operating revenue from January to June 2024 was 56.2169 million yuan, an increase of 26.23% compared to the same period last year. Net profit was 7.4343 million yuan, an increase of 10.38% compared to the same period last year., earnings per share 0.07 yuan, return on net assets 4.03%, operating cash flow per share -0.1337 yuan, and gross profit margin of sales 51.03%.
GOC2025 Zone
Ophthalmology Solutions Case
Ophthalmic Instruments Industry Research
